| BAP1 deficiency inflames the tumor immune microenvironment and is a candidate biomarker for immunotherapy response in malignant pleural mesothelioma D Xu, Y Gao, H Yang, M Spils, TM Marti, T Losmanová, M Su, W Wang, ... JTO clinical and research reports 5 (5), 100672, 2024 | | 2024 |
| Treatment patterns and clinical outcomes of resectable NSCLC receiving neoadjuvant immunochemotherapy: a large-scale, multicenter, real-world study (NeoR-World). Z Yang, S Wang, H Yang, Y Jiang, L Zhu, B Zheng, H Fu, J Ma, H Xie, ... The Journal of Thoracic and Cardiovascular Surgery, S0022-5223 (24) 00111, 2024 | 2 | 2024 |
| Photoactive Poly-L-Lysine gel with resveratrol-magnesium metal polyphenol network: A promising strategy for preventing tracheal anastomotic complications following surgery Y Jia, J Shi, B Ding, L Zhao, K Xu, C Hu, W Xu, A Zhu, H Yang, X Wang, ... Materials Today Bio 24, 100938, 2024 | | 2024 |
| One‐Pot Synthesis of Tumor‐Microenvironment Responsive Degradable Nanoflower‐Medicine for Multimodal Cancer Therapy with Reinvigorating Antitumor Immunity J Sun, K Jiang, Y Wang, Y Liu, T Wang, S Ding, X Zhang, W Xiong, ... Advanced Healthcare Materials 12 (31), 2302016, 2023 | 1 | 2023 |
| Effectiveness comparison of third-generation EGFR-TKI as initial and sequential therapy in adjuvant treatment for EGFR mutation-sensitive stage IIIA non-small cell lung cancer … W Ma, Z Sheng, Y Niu, B Yan, Y Chen, H Yang, R Li Heliyon 9 (11), 2023 | 1 | 2023 |
| " Keaping" an Eye on the NRF2 Signature Score: Expanding Its Applicability in Lung Cancer Y Niu, F Yao, H Yang Journal of thoracic oncology: official publication of the International …, 2023 | | 2023 |
| Multienzyme‐Mimicking LaCoO3 Nanotrigger for Programming Cancer‐Cell Pyroptosis K Xu, M Chang, Z Wang, H Yang, Y Jia, W Xu, B Zhao, Y Chen, F Yao Advanced materials 35 (35), 2302961, 2023 | 23 | 2023 |
| A non-canonical function of LDHB promotes SLC7A11-mediated glutathione metabolism and protects against glutaminolysis-dependent ferroptosis in KRAS-driven … L Zhao, H Deng, J Zhang, N Zamboni, GA Geest, H Yang, Z Yang, Y Gao, ... bioRxiv, 2023.02. 12.525859, 2023 | 2 | 2023 |
| MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma H Yang, Y Gao, D Xu, K Xu, SQ Liang, Z Yang, A Scherz, SRR Hall, ... Cell death discovery 9 (1), 55, 2023 | 9 | 2023 |
| Phosphorylation by IKKβ promotes the degradation of HMGCL via NEDD4 in lung cancer C Zhong, G Xiong, H Yang, X Du, J Du, F Yao, W Fang, Y Deng International Journal of Biological Sciences 19 (4), 1110, 2023 | 5 | 2023 |
| Battles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networks K Xu, J Ma, SRR Hall, RW Peng, H Yang, F Yao Theranostics 13 (2), 704, 2023 | 19 | 2023 |
| Functional and molecular characterization of PD1+ tumor-infiltrating lymphocytes from lung cancer patients JJ Lipp, L Wang, H Yang, F Yao, N Harrer, S Müller, S Berezowska, ... Oncoimmunology 11 (1), 2019466, 2022 | 6 | 2022 |
| IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer Y He, W Luo, Y Liu, Y Wang, C Ma, Q Wu, P Tian, D He, Z Jia, X Lv, ... The Journal of Clinical Investigation 132 (20), 2022 | 37 | 2022 |
| Multi-scale characterization of tumor-draining lymph nodes in resectable lung cancer treated with neoadjuvant immune checkpoint inhibitors H Yang, B Sun, W Ma, L Fan, K Xu, Y Jia, J Xu, Z Wang, F Yao EBioMedicine 84, 2022 | 16 | 2022 |
| Revisiting “BAP1ness” in malignant pleural mesothelioma H Yang, F Yao, RW Peng Journal of Thoracic Oncology 17 (8), e67-e69, 2022 | 2 | 2022 |
| The improved success rate and reduced complications of a novel localization device vs. hookwire for thoracoscopic resection of small pulmonary nodules: a single-center, open … L Fan, W Ma, J Ma, L Yang, Z Wang, K Xu, Y Jia, B Sun, JC Sieren, ... Translational lung cancer research 11 (8), 1702, 2022 | 3 | 2022 |
| Indocyanine green fluorescence-navigated thoracoscopy versus traditional inflation-deflation approach in precise uniportal segmentectomy: a short-term outcome comparative study W Fan, H Yang, J Ma, Z Wang, H Zhao, F Yao Journal of Thoracic Disease 14 (3), 741, 2022 | 10 | 2022 |
| Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer Z Yang, SQ Liang, L Zhao, H Yang, TM Marti, B Hegedüs, Y Gao, B Zheng, ... Journal of experimental & clinical cancer research 41 (1), 25, 2022 | 9 | 2022 |
| Multi-scale integrative analyses identify THBS2+ cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma H Yang, B Sun, L Fan, W Ma, K Xu, SRR Hall, Z Wang, RA Schmid, ... Theranostics 12 (7), 3104, 2022 | 39 | 2022 |
| Implementation of smoking signature as an improved biomarker predicting the response to immunotherapy H Yang, W Ma, F Yao Translational Lung Cancer Research 11 (1), 124-125, 2022 | 1 | 2022 |
